Published in J Clin Endocrinol Metab on February 01, 2005
Osteoclasts: what do they do and how do they do it? Am J Pathol (2007) 2.93
Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol (2007) 2.27
Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov (2010) 2.27
Talin1 and Rap1 are critical for osteoclast function. Mol Cell Biol (2012) 1.68
Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis. Maturitas (2010) 1.51
Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res Ther (2005) 1.43
Integrin targeted therapeutics. Theranostics (2011) 1.36
Giant cell formation and function. Curr Opin Hematol (2009) 1.30
Involvement of alpha(v)beta3 integrins in osteoclast function. J Bone Miner Metab (2007) 1.23
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther (2006) 1.20
Therapeutic targets for bone metastases in breast cancer. Breast Cancer Res (2011) 1.16
Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol (2013) 1.10
Integrins and bone metastasis: integrating tumor cell and stromal cell interactions. Bone (2010) 1.09
Targeting integrins to promote bone formation and repair. Nat Rev Endocrinol (2013) 1.02
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.01
Novel strategies for the treatment of chondrosarcomas: targeting integrins. Biomed Res Int (2013) 0.98
Emerging therapies for the treatment of osteoporosis. J Midlife Health (2013) 0.93
Current, new and future treatments of osteoporosis. Rheumatol Int (2010) 0.92
Integrins, insulin like growth factors, and the skeletal response to load. Osteoporos Int (2008) 0.88
A novel role for SED1 (MFG-E8) in maintaining the integrity of the epididymal epithelium. J Cell Sci (2009) 0.88
Osteoporosis and integrins. J Clin Endocrinol Metab (2005) 0.86
Strategies of spinal fusion on osteoporotic spine. J Korean Neurosurg Soc (2011) 0.86
Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis. J Cell Biol (2014) 0.83
Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasis. Oncol Rep (2015) 0.79
The osteoporosis revolution marches on. J Orthop Sci (2007) 0.75
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide. Clin Cancer Res (2015) 0.75
The vasculature: a vessel for bone metastasis. Bonekey Rep (2015) 0.75
Prevalent and Emerging Therapies for Osteoporosis. Med J Armed Forces India (2011) 0.75
An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model. Pharmacol Res Perspect (2017) 0.75
The sequence of the human genome. Science (2001) 101.55
Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA (1998) 5.09
A simple colorimetric method for determination of protein. Anal Biochem (1969) 4.87
Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations. Obes Rev (2006) 4.74
Cell cycle dynamics of an M-phase-specific cytoplasmic factor in Xenopus laevis oocytes and eggs. J Cell Biol (1984) 4.20
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
Actin-dependent propulsion of endosomes and lysosomes by recruitment of N-WASP. J Cell Biol (2000) 3.71
Genome of Geobacter sulfurreducens: metal reduction in subsurface environments. Science (2003) 3.68
Cell cycle tyrosine phosphorylation of p34cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs. Mol Cell Biol (1991) 2.69
Genetic relationship of populations in China. Proc Natl Acad Sci U S A (1998) 2.65
Oxidative damage and protection of the RPE. Prog Retin Eye Res (2000) 2.65
A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med (1992) 2.57
Partial purification and characterization of the maturation-promoting factor from eggs of Xenopus laevis. Dev Biol (1980) 2.53
Lithium phthalocyanine: a probe for electron paramagnetic resonance oximetry in viable biological systems. Proc Natl Acad Sci U S A (1993) 2.50
Establishment of the dorso-ventral axis in Xenopus embryos is presaged by early asymmetries in beta-catenin that are modulated by the Wnt signaling pathway. J Cell Biol (1997) 2.42
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab (2000) 2.34
An approximate generalized linear model with random effects for informative missing data. Biometrics (1995) 2.34
Changes in protein phosphorylation accompanying maturation of Xenopus laevis oocytes. Dev Biol (1977) 2.31
Polyadenylation of c-mos mRNA as a control point in Xenopus meiotic maturation. Nature (1995) 2.21
Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet (1991) 2.15
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer (1994) 2.14
Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell (2001) 2.11
Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes (1997) 2.10
Three-year maintenance of improved diet and physical activity: the CATCH cohort. Child and Adolescent Trial for Cardiovascular Health. Arch Pediatr Adolesc Med (1999) 2.07
Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene (2001) 2.05
Secreted noggin protein mimics the Spemann organizer in dorsalizing Xenopus mesoderm. Nature (1993) 2.02
Structure of a nicked DNA-protein complex isolated from simian virus 40: covalent attachment of the protein to DNA and nick specificity. Proc Natl Acad Sci U S A (1976) 1.95
Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor. J Immunol (1989) 1.92
Use of gene 32 protein staining of single-strand polynucleotides for gene mapping by electron microscopy: application to the phi80d3ilvsu+7 system. Proc Natl Acad Sci U S A (1975) 1.92
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer (2010) 1.90
TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity (1996) 1.81
The effect of moxifloxacin on QTc and implications for the design of thorough QT studies. Clin Pharmacol Ther (2008) 1.80
An intervening sequence in an unusual histone H1 gene of Tetrahymena thermophila. Proc Natl Acad Sci U S A (1986) 1.79
Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res (1995) 1.76
MTO1 codes for a mitochondrial protein required for respiration in paromomycin-resistant mutants of Saccharomyces cerevisiae. J Biol Chem (1998) 1.72
Physical mapping of the transfer RNA genes on lambda-h80dglytsu+36. J Mol Biol (1973) 1.72
Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci U S A (1993) 1.71
Alpha-amanitin resistant transcription of protein coding genes in insect and bloodstream form Trypanosoma brucei. EMBO J (1989) 1.70
The role of cyclin synthesis, modification and destruction in the control of cell division. J Cell Sci Suppl (1989) 1.69
Expression of the mitochondrial genome in HeLa cells. XIV. The relative positions of the 4 S RNA genes and of the ribosomal RNA genes in mitochondrial DNA. J Mol Biol (1972) 1.68
High incidence of single nucleotide substitutions in the mitochondrial genome is associated with poor semen parameters in men. Int J Androl (2001) 1.68
Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci U S A (1994) 1.65
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry (2001) 1.63
Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63
The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels. Endocrinology (2002) 1.59
Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis (1988) 1.58
Nutrition education at the point of purchase: the foods for health project evaluated. Prev Med (1986) 1.56
Mitochondrial and cytoplasmic fumarases in Saccharomyces cerevisiae are encoded by a single nuclear gene FUM1. J Biol Chem (1987) 1.56
Regulation of NKB pathways and their roles in the control of Kiss1 neurons in the arcuate nucleus of the male mouse. Endocrinology (2011) 1.55
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend (2000) 1.55
Sequence arrangement of tRNA genes on a fragment of Drosophila melanogaster DNA cloned in E. coli. Cell (1977) 1.54
On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab (1999) 1.53
Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice. Antimicrob Agents Chemother (1989) 1.52
A randomized trial of a self-help smoking cessation intervention in a nonvolunteer female population: testing the limits of the public health model. Health Psychol (1992) 1.51
Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes. Int J Clin Pract (2006) 1.50
Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin. J Infect Dis (1987) 1.49
Intestinal uptake of macromolecules. III. Studies on the mechanism by which immunization interferes with antigen uptake. J Immunol (1975) 1.49
In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex. J Infect Dis (1989) 1.44
Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease. Control Clin Trials (1993) 1.43
Enrichment of rab11, a small GTP-binding protein, in gastric parietal cells. Am J Physiol (1994) 1.43
The remineralizing effect of an essential oil fluoride mouthrinse in an intraoral caries test. J Am Dent Assoc (2004) 1.42
Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect Immun (1992) 1.42
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clin Pharmacol Ther (2007) 1.39
Protein-SV40 DNA complex stable in high salt and sodium dodecyl sulfate. Biochem Biophys Res Commun (1976) 1.38
Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am J Hum Genet (2000) 1.37
Endoplasmic reticulum dynamics, inheritance, and cytoskeletal interactions in budding yeast. Mol Biol Cell (2002) 1.37
FLX1 codes for a carrier protein involved in maintaining a proper balance of flavin nucleotides in yeast mitochondria. J Biol Chem (1996) 1.36
Microtubule-mediated transport of organelles and localization of beta-catenin to the future dorsal side of Xenopus eggs. Proc Natl Acad Sci U S A (1997) 1.36
Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol (1992) 1.36
The stability and structure of tandem GA mismatches in RNA depend on closing base pairs. Biochemistry (1994) 1.35
Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med (1995) 1.35
Stimulation by immune complexes of mucus release from goblet cells of the rat small intestine. Science (1977) 1.35
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia (2012) 1.35
Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res (1994) 1.33
Electron microscopic localization of the chloroplast DNA replicative origins in Chlamydomonas reinhardii. Nucleic Acids Res (1984) 1.32
Piericidin A: a new inhibitor of mitochondrial electron transport. Biochem Biophys Res Commun (1966) 1.32
Cardiovascular risk factors among children after a 2 1/2-year intervention-The CATCH Study. Prev Med (1996) 1.31
Mefloquine is active in vitro and in vivo against Mycobacterium avium complex. Antimicrob Agents Chemother (1999) 1.29
Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation. J Acquir Immune Defic Syndr (2001) 1.29
Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence. Arch Virol (2001) 1.29
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem (1996) 1.28
Social functioning and overall mortality: prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Epidemiology (1994) 1.28
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol (2000) 1.27
Secondary structure in transfer RNA genes. J Mol Biol (1973) 1.27
Quantifying the energetic interplay of RNA tertiary and secondary structure interactions. RNA (1999) 1.27
Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology (1999) 1.27
Antigenic variation in African trypanosomes. Trends Genet (1992) 1.26
Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin Pharmacol Ther (2009) 1.24
A technique for mapping transfer RNA genes by electron microscopy of hybrids of ferritin-labeled transfer RNA and DNA: the phi-80hpsu+3-system. J Mol Biol (1973) 1.24
Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity. Mol Med (1996) 1.24
Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice. Antimicrob Agents Chemother (1996) 1.23
Electron microscopic mapping of RNA transcribed from the late region of polyoma virus DNA. J Virol (1979) 1.22
Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science (1994) 1.22
Structure of the inverted terminal repetition of adenovirus type 2 DNA. J Virol (1977) 1.20
Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob Agents Chemother (2001) 1.20
M-phase promoting factors from eggs of Xenopus laevis. Cytobios (1985) 1.20
[Relationship between growth potential of pine, population density of Monochamus alternatus and pathogenicity of Bursaphlenchus xyloophilus]. Ying Yong Sheng Tai Xue Bao (2001) 1.20
Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res (1994) 1.19
Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab (1998) 1.19